Judge Keeps BMS Securities Suit In Play

Law360, New York (August 20, 2008, 12:00 AM EDT) -- A federal judge has denied Bristol-Myers Squibb Co.'s motion to dismiss a securities class action that accuses BMS of duping shareholders and causing a stock drop when it failed to properly disclose a patent deal for a generic version of its blood-thinning drug Plavix.

Judge Paul A. Crotty in the U.S. District Court for the Southern District of New York handed down the order Tuesday, denying BMS and former executives Peter Dolan and Andrew Bodnar's motion to dismiss an amended complaint filed jointly by the Ontario...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.